Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)

Peeter Karihtala

Helsinki, FI 
Advanced in Diffuse Large B-Cell Lymphoma (DLBCL)
Helsinki, FI 
OverviewLocationsClinical Research

Overview

Peeter Karihtala practices in Helsinki, Finland. Karihtala is rated as an Advanced expert by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Their top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Febrile Neutropenia, and Diffuse Large B-Cell Lymphoma (DLBCL).

Their clinical research consists of co-authoring 129 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Diffuse Large B-Cell Lymphoma (DLBCL).

Locations

Helsinki, Finland
Other Locations
Oulu, Finland
Box, 00029, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3

129 Total Publications

Gut microbiota-derived extracellular vesicles form a distinct entity from gut microbiota.
Gut microbiota-derived extracellular vesicles form a distinct entity from gut microbiota.
Journal: mSystems
Published: April 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Karihtala's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile